First Graphene Brain-Computer Interface Implanted

InBrain Neuroelectronics has successfully implanted the world's first brain-computer interface (BCI) made from graphene in a patient undergoing brain tumor resection at Salford Royal Hospital, UK. This pioneering procedure demonstrated the device's ability to distinguish between healthy and cancerous brain tissue at a micrometer scale, marking a significant advancement in neurotechnology. Graphene's unique properties, including its strength and electrical conductivity, enhance the performance of BCIs, potentially transforming surgical procedures and therapeutic applications. Dr. David Coope, the chief clinical investigator, emphasized that graphene's high signal fidelity allows for precise brain activity monitoring, thus preserving essential functions like movement and cognition. The study aims to assess the safety and effectiveness of this technology in a small group of patients, further exploring its implications for precision surgery and neural decoding. InBrain's innovation represents a crucial step towards integrating advanced materials into medical applications, fostering a new era in brain-computer interfaces.